AR224400A1 - Procedimiento para la preparacion de derivados de 4-amino-6,7-di(alcoxi c1-4)-2-piperazino-quinazolina - Google Patents

Procedimiento para la preparacion de derivados de 4-amino-6,7-di(alcoxi c1-4)-2-piperazino-quinazolina

Info

Publication number
AR224400A1
AR224400A1 AR280773A AR28077380A AR224400A1 AR 224400 A1 AR224400 A1 AR 224400A1 AR 280773 A AR280773 A AR 280773A AR 28077380 A AR28077380 A AR 28077380A AR 224400 A1 AR224400 A1 AR 224400A1
Authority
AR
Argentina
Prior art keywords
alcoxi
piperazino
quinazoline
derivatives
amino
Prior art date
Application number
AR280773A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10504770&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR224400(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR224400A1 publication Critical patent/AR224400A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AR280773A 1979-04-25 1980-04-23 Procedimiento para la preparacion de derivados de 4-amino-6,7-di(alcoxi c1-4)-2-piperazino-quinazolina AR224400A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914431 1979-04-25

Publications (1)

Publication Number Publication Date
AR224400A1 true AR224400A1 (es) 1981-11-30

Family

ID=10504770

Family Applications (1)

Application Number Title Priority Date Filing Date
AR280773A AR224400A1 (es) 1979-04-25 1980-04-23 Procedimiento para la preparacion de derivados de 4-amino-6,7-di(alcoxi c1-4)-2-piperazino-quinazolina

Country Status (33)

Country Link
US (1) US4279910A (de)
JP (1) JPS55145684A (de)
KR (1) KR830002567B1 (de)
AR (1) AR224400A1 (de)
AT (1) AT373596B (de)
BE (1) BE882967A (de)
CA (1) CA1132558A (de)
CH (1) CH642076A5 (de)
CS (1) CS209950B2 (de)
DD (1) DD150202A5 (de)
DE (1) DE3015676A1 (de)
DK (1) DK121080A (de)
EG (1) EG14651A (de)
ES (1) ES490867A0 (de)
FI (1) FI64592C (de)
FR (1) FR2455042A1 (de)
GB (1) GB2049683B (de)
GR (1) GR68049B (de)
HU (1) HU184747B (de)
IE (1) IE49705B1 (de)
IL (1) IL59900A (de)
IT (1) IT1141490B (de)
LU (1) LU82394A1 (de)
NL (1) NL182563C (de)
NO (1) NO152508C (de)
NZ (1) NZ193511A (de)
PH (1) PH15156A (de)
PL (1) PL121470B1 (de)
PT (1) PT71139A (de)
SE (1) SE435061B (de)
SU (1) SU915804A3 (de)
YU (1) YU41709B (de)
ZA (1) ZA802488B (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4140776A (en) * 1977-09-16 1979-02-20 Merck & Co., Inc. N-pyrazinecarbonyl-N'-acylguanidines
GB2007656B (en) * 1977-11-05 1982-05-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
ES8101588A1 (es) 1980-12-16
DE3015676A1 (de) 1980-11-13
NL182563C (nl) 1988-04-05
ES490867A0 (es) 1980-12-16
FR2455042A1 (fr) 1980-11-21
YU41709B (en) 1987-12-31
IE800827L (en) 1980-10-25
IL59900A (en) 1983-11-30
YU113180A (en) 1983-02-28
SU915804A3 (en) 1982-03-23
DK121080A (da) 1980-10-26
NZ193511A (en) 1982-03-30
CS209950B2 (en) 1981-12-31
IL59900A0 (en) 1980-06-30
LU82394A1 (fr) 1980-07-31
FI801306A (fi) 1980-10-26
ATA218980A (de) 1983-06-15
KR830002567B1 (ko) 1983-11-14
CA1132558A (en) 1982-09-28
SE435061B (sv) 1984-09-03
PT71139A (en) 1980-05-01
AT373596B (de) 1984-02-10
NL182563B (nl) 1987-11-02
SE8003122L (sv) 1980-10-26
NO152508B (no) 1985-07-01
GB2049683B (en) 1983-01-26
GR68049B (de) 1981-10-29
IE49705B1 (en) 1985-11-27
JPS55145684A (en) 1980-11-13
NL8002387A (nl) 1980-10-28
BE882967A (fr) 1980-10-24
JPS5738591B2 (de) 1982-08-16
HU184747B (en) 1984-10-29
PH15156A (en) 1982-08-24
NO152508C (no) 1985-10-09
IT1141490B (it) 1986-10-01
FI64592C (fi) 1983-12-12
PL223755A1 (de) 1981-02-13
FR2455042B1 (de) 1983-05-20
IT8021598A0 (it) 1980-04-23
CH642076A5 (de) 1984-03-30
NO801196L (no) 1980-10-27
EG14651A (en) 1985-03-31
FI64592B (fi) 1983-08-31
GB2049683A (en) 1980-12-31
ZA802488B (en) 1981-08-26
PL121470B1 (en) 1982-05-31
DD150202A5 (de) 1981-08-19
KR830002758A (ko) 1983-06-30
US4279910A (en) 1981-07-21

Similar Documents

Publication Publication Date Title
AR220004A1 (es) Procedimiento para la preparacion de derivados de 4,4-dimetil-2-imidazolidinona
ES508618A0 (es) Procedimiento para la preparacion de derivados de la quino- lina.
ES498071A0 (es) Procedimiento para la preparacion de 2-acilaminometil-1h-2,3-dihidro-1,4-benzodiazepinas
MX5934E (es) Procedimiento para la preparacion de 1-substituido-4,5-diaril-2-(tiosubstituido)imidazoles
ES492566A0 (es) Procedimiento para la preparacion de nuevos derivados de en-cafalina
AR221851A1 (es) Procedimiento para la preparacion de derivados de 4-piperidino-6,7-dialcoxi-quinazolina
ES496019A0 (es) Procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo
ES556514A0 (es) Procedimiento para la preparacion de derivados de 2-oxi-4h-3, 1-benzoxazin-4-ona
ES493985A0 (es) Procedimiento para la preparacion de nuevos derivados de urea
AR228011A1 (es) Procedimiento para la preparacion de derivados sustituidos de 2,5,5,8a-tetrametil-1,2,3,4,4a,5,6,7,8,8a-decahidronaftaleno-1-spiro-2'-(4',6',7'-sustituido-2',3'-dihidrobenzofurano)
MX5256E (es) Procedimiento para la preparacion de derivados de 20,21-dinoreburnamenina
AR217688A1 (es) Procedimiento para la preparacion de derivados de trans-2-sustituido-5-aril-2,3,4,4a,5,9b-hexahidro-1h-pirido(4,3-b)-indol
ES494291A0 (es) Procedimiento para la preparacion de derivados diazoicos.
ES497530A0 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
ES522213A0 (es) Procedimiento para la preparacion de derivados de quinazolina.
ES501213A0 (es) Procedimiento para la preparacion de derivados de 2,3,4,5- tetrahidro-1-benzoxepin-3,5-diona
MX5933E (es) Procedimiento para la preparacion de 4,5-diciclo-2-(tiosubstituidos)-imidazoles
AR218060A1 (es) Procedimiento para la preparacion de derivados de acido 11-oxo-11h-pirido(2,1-b)quinazolina-2-carboxilico
ES520537A0 (es) Procedimiento para la preparacion de derivados de carbaciclina.
MX6009E (es) Procedimiento para la preparacion de tetrahidro-1,3,5-tiadiazin-4-onas
ES494211A0 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.
ES493649A0 (es) Procedimiento para la fabricacion de 4-tiazolidonas,2-subs- tituidas
ES497562A0 (es) Procedimiento para la preparacion catalitica de tieno(3,2-c)piridina
AR224400A1 (es) Procedimiento para la preparacion de derivados de 4-amino-6,7-di(alcoxi c1-4)-2-piperazino-quinazolina
ES496505A0 (es) Procedimiento para la preparacion de carbamilderivados de &-hidroxiacidos.